The European Union still wants a trade pact with the US, but the bloc said to be readying its counterattack as President ...

Beijing is betting that economic pressure and diplomatic defiance will force concessions, but its stance could put more ...

China's Ministry of State Security says it is cracking down on alleged smuggling of rare earths materials that it says ...

US President Donald Trump has threatened to impose a 200% tariff on pharmaceutical imports into the United States, and while ...

Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.

Multinationals are attracted to Chinese biotech companies' cost efficiencies, accelerated timelines and promising quality, ...

Tariff policies are changing so rapidly that it can be hard to keep up. Here are all of President Donald Trump's proposed, ...

Since US President Donald Trump – just days into his second term – began imposing tariffs on China for its role in the flow ...

President Trump is amping up trade threats, again unveiling a new batch of letters to country leaders outlining tariffs on ...

Trump floats 200% tariff on medicines, while threat of 50% levy on copper imports sent price of metal to record high ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their first serious rival in China.